ExodusPoint Capital Management LP Acquires New Holdings in Schrödinger, Inc. (NASDAQ:SDGR)

ExodusPoint Capital Management LP purchased a new position in shares of Schrödinger, Inc. (NASDAQ:SDGR - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 14,495 shares of the company's stock, valued at approximately $280,000.

A number of other large investors also recently modified their holdings of SDGR. Paradigm Asset Management Co. LLC purchased a new position in shares of Schrödinger during the fourth quarter worth about $50,000. GAMMA Investing LLC raised its holdings in shares of Schrödinger by 87.5% in the fourth quarter. GAMMA Investing LLC now owns 2,796 shares of the company's stock valued at $54,000 after buying an additional 1,305 shares during the last quarter. KBC Group NV lifted its position in Schrödinger by 73.9% during the 4th quarter. KBC Group NV now owns 4,361 shares of the company's stock worth $84,000 after acquiring an additional 1,853 shares during the period. Proficio Capital Partners LLC purchased a new position in Schrödinger in the 4th quarter valued at $218,000. Finally, KLP Kapitalforvaltning AS acquired a new position in shares of Schrödinger during the fourth quarter worth about $264,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

SDGR has been the subject of a number of research analyst reports. KeyCorp increased their target price on shares of Schrödinger from $25.00 to $27.00 and gave the company an "overweight" rating in a report on Friday, January 24th. Piper Sandler dropped their price target on Schrödinger from $50.00 to $45.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Buy" and an average target price of $32.29.

Remove Ads

Insider Activity at Schrödinger

In other Schrödinger news, CFO Geoffrey Craig Porges sold 5,491 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $21.76, for a total transaction of $119,484.16. Following the transaction, the chief financial officer now owns 27,544 shares of the company's stock, valued at $599,357.44. This trade represents a 16.62 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Karen Akinsanya sold 16,723 shares of the firm's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $25.09, for a total value of $419,580.07. Following the transaction, the insider now owns 15,625 shares in the company, valued at $392,031.25. This trade represents a 51.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 8.60% of the company's stock.

Schrödinger Stock Performance

SDGR traded down $0.95 on Tuesday, reaching $25.59. 2,903,341 shares of the company's stock were exchanged, compared to its average volume of 815,073. The company has a market cap of $1.87 billion, a price-to-earnings ratio of -10.94 and a beta of 1.77. Schrödinger, Inc. has a twelve month low of $16.60 and a twelve month high of $28.47. The company's 50 day moving average is $21.98 and its 200-day moving average is $20.84.

Schrödinger (NASDAQ:SDGR - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported ($0.55) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.20). Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The business had revenue of $88.32 million for the quarter, compared to analyst estimates of $83.20 million. Sell-side analysts forecast that Schrödinger, Inc. will post -2.37 EPS for the current year.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.